HR 5605

The Medical Device Nonvisual Accessibility Act of 2025 aims to make medical devices with digital interfaces more accessible to people who are blind or have low-vision. It requires the Food and Drug Administration to establish standards for nonvisual accessibility, ensuring these devices are usable with screen access technology or other compatible methods. The bill also creates a process for manufacturers to request waivers if compliance would be too costly or significantly alter the device’s function, and mandates training for manufacturers on these new accessibility requirements.